ESSA Pharma's securityholders approve acquisition by XenoTherapeutics, acquiring all common shares.

Unusual Whales
2025.10.06 21:16
On October 6, 2025, ESSA Pharma Inc. (NASDAQ: EPIX) based in South San Francisco, USA, and Vancouver, Canada, revealed the approval from its Securityholders for the acquisition of all the common shares. The acquisition includes all of the issued and outstanding common shares of the company. This strategic move marks a significant milestone for ESSA as it advances its growth strategy.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer